Kimberly-Clark Corporation (KMB) - FREE Research Report

Jemison Mae who is Director at Kimberly-Clark Corporation sold 130 shares at $107.97 on Dec. 2, 2013. Following this transaction, the Director owned 0 shares meaning that the stake was reduced by 100% with the 130-share transaction.

Abernathy Robert E who is Executive Vice President at Kimberly-Clark Corporation sold 13,098 shares at $108.00 on Dec. 2, 2013. Following this transaction, the Executive Vice President owned 95,188 shares meaning that the stake was reduced by 12.1% with the 13,098-share transaction.

The shares most recently traded at $106.11, down $1.89, or 1.78% since the insider transaction. Historical insider transactions for Kimberly-Clark Corporation go as follows:

  • 4-Week # shares sold: 5,000
  • 12-Week # shares bought: 2,000
  • 12-Week # shares sold: 5,000
  • 24-Week # shares bought: 2,000
  • 24-Week # shares sold: 10,000

The average volume for Kimberly-Clark Corporation has been 1.7 million shares per day over the past 30 days. Kimberly-Clark Corporation has a market cap of $41.7 billion and is part of the consumer goods sector and consumer non-durables industry. Shares are up 29.29% year-to-date as of the close of trading on Monday.

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care, consumer tissue, and health care products worldwide. The company operates in four segments: Personal Care, Consumer Tissue, K-C Professional, and Health Care. The stock currently has a dividend yield of 2.97%. The company has a P/E ratio of 22.6. Currently there are 2 analysts that rate Kimberly-Clark Corporation a buy, 1 analyst rates it a sell, and 9 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on KMB - FREE

TheStreet Quant Ratings rates Kimberly-Clark Corporation as a buy. The company's strengths can be seen in multiple areas, such as its increase in stock price during the past year, growth in earnings per share, revenue growth, good cash flow from operations and expanding profit margins. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full Kimberly-Clark Corporation Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you liked this article you might like

Elizabeth Warren Slams Wells Fargo, Equifax: Cramer's Top Takeaways

Centene: Cramer's Top Takeaways

The Pitney Bowes Transformation: Cramer's Top Takeaways

Healthcare Trust of America, Marathon Petroleum: 'Mad Money' Lightning Round

How Long Can This Rally Run?: Cramer's 'Mad Money' Recap (Monday 9/19/17)